Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Novo Nordisk Stock Popped Today


Novo Nordisk (NYSE: NVO) -- the original Ozempic stock -- is getting a boost from a Financial Times report this morning highlighting positive results from two weight loss trials using increased dosages of semaglutide (the active ingredient in Ozempic).

Novo Nordisk stock is responding positively to the news, up 2.1% through 10:55 a.m. ET.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
NVO
Share

Comments